3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Sarcoma
2
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrence
1
Medulloblastoma
1
Ependymoma
1
Brain Neoplasms
1
Interventions
Temozolomide
25
Magnetic Resonance Spectroscopy
19
Etoposide
14
Cyclophosphamide
13
Radiotherapy
10
Filgrastim
10
Bevacizumab
10
Carboplatin
9
Biopsy
8
Cisplatin
7
X-Rays
6
Thiotepa
6
Specimen Handling
6
Phantoms, Imaging
6
Carmustine
6
Radiation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Irinotecan
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
sargramostim
4
Vincristine
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Erlotinib Hydrochloride
4
Azacitidine
4
etoposide phosphate
3
Surgical Procedures, Operative
3
Lapatinib
3
Granulocyte Colony-Stimulating Factor
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Ependymoma
×
trofosfamide
×
Clear all
NCT00749723
2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3
Completed
174 enrolled